Atacama Labs offers specialized oral solid dosage form development.

This gives you

• Pre-/formulations for new chemical entities (NCE) in phase 1-2 where dissolution, stability, water and/or heat problems need a creative solution
  
• New formulations for known APIs in life cycle management for differentiation where new orally disintegrating tablet (ODT) formulas, high drug loadings with smaller tablets or difficult fixed-dose combinations (FDC) may lead to higher market share
  
• New formulations for excipients, flavours or nutraceuticals where flowability and other parameters may be an issue
  

We can provide individual and integrated solutions for your development needs. Following your specification of API characteristics and target profile we propose:

• Very fast feasibility studies (typically within 2 weeks, API volume from 1 kg onward)
  
• Full galenic development (typically within 8 weeks)
  
• Analytical evaluation services to correspond to your set goal
  
• Clinical supply and packaging
  

Of course, you can also select any of these services on an individual basis. Our development team has the experience and expertise that you can rely on. We can respond immediately with the capacity, facilities, and equipment to meet your needs, and work directly with manufacturing and packaging services. 

Atacama Labs utilizes the PDG Technology™ also for formulating its own product portfolio, containing proprietary and patent protected products across multiple therapeutical areas.